Loading
Latest filing published 20 Sept 2019 for MusclePharm Corp, €44k.
No signal scores available.
This profile gathers the share dealings of Ryan Charles Drexler in MusclePharm Corp. In total, 7 filings cover trades dated from 24 July 2015 to 16 September 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 20 September 2019 came the latest disclosure, a transaction for €16.4M in MusclePharm Corp. Typically, a trade is published a median of 37 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations